Viewing StudyNCT00363012



Ignite Creation Date: 2024-05-05 @ 4:59 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00363012
Status: COMPLETED
Last Update Posted: 2017-04-05
First Post: 2006-08-10

Brief Title: Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
Sponsor: University of Washington
Organization: University of Washington

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-04
Start Date Type: None
Primary Completion Date: 2010-03
Primary Completion Date Type: ACTUAL
Completion Date: 2010-03
Completion Date Type: ACTUAL
First Submit Date: 2006-08-10
First Submit QC Date: August 10 2006
Study First Post Date: 2006-08-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2017-04-03
Disp First Submit QC Date: April 3 2017
Disp First Post Date: 2017-04-05
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2017-04-03
Last Update Post Date: 2017-04-05
Last Update Post Date Type: ACTUAL